Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1463-1326.2004.00398.xPMID 15811143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological Detection of a Novel Advanced Glycation End-Product

  2001cited by this paper
• N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.

  2001cited by this paper
• The missing link: a single unifying mechanism for diabetic complications.

  2000cited by this paper
• Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.

  1999cited by this paper
• The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

  1998cited by this paper
• N[ε]-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction(カルボキシメチルリジン付加体はメイラード反応後期生成物の主要エピトープある)

  1997cited by this paper
• Increased Serum Levels of Advanced Glycation End Products (AGEs) in Children and Adolescents With IDDM

  1997cited by this paper
• Salt Restriction Reduces Hyperfiltration, Renal Enlargement, and Albuminuria in Experimental Diabetes

  1997cited by this paper
• Recent Progress in Advanced Glycation End Products and Diabetic Complications

  1997cited by this paper
• Crossline-like Structure Accumulates as Fluorescent Advanced Glycation End Products in Renal Tissues of Rats with Diabetic Nephropathy

  1996cited by this paper
• N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

  1996cited by this paper
• N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

  1995cited by this paper
• Novel Imidazolone Compound Formed by the Advanced Maillard Reaction of 3-Deoxyglucosone and Arginine Residues in Proteins

  1994cited by this paper
• Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Hemoglobin-AGE: a circulating marker of advanced glycosylation.

  1992cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper
• Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.

  1991cited by this paper
• Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

  1989cited by this paper
• Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo.

  1989cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

  1986cited by this paper

• Synergistic modulation of myofibrillar protein self-assembly in aqueous systems via nonenzymatic glycation and amino acid supplementation.

  2025cites this paper
• From diabetic hyperglycemia to cerebrovascular Damage: A narrative review.

  2023cites this paper
• HILIC UPLC/ QTof MS Method Development for the Quantification of AGEs Inhibitors - Trouble Shooting Protocol.

  2023cites this paper
• Serum fibroblast growth factor-21 levels and its relationship with carotid intima-media thickness in type 1 diabetes mellitus patients

  2022cites this paper
• Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.

  2021cites this paper
• A Comprehensive Review of Neuronal Changes in Diabetics

  2021cites this paper
• Advanced glycation end products in food and their effects on intestinal tract

  2020cites this paper
• Les réactions d’oxydation des protéines et leurs biomarqueurs

  2020cites this paper
• Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

  2018cites this paper
• Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction

  2017cites this paper
• Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control.

  2016cites this paper
• Flavonoids: Prospective Strategy for the Management of Diabetes and Its Associated Complications

  2016cites this paper
• Genetic diversity in chestnuts of Kashmir valley

  2016cites this paper
• Allium sativum aqueous extract inhibitory effect on advanced glycation end product

  2014cites this paper
• Nε-carboxymethyllysine-mediated endoplasmic reticulum stress promotes endothelial cell injury through Nox4/MKP-3 interaction.

  2014cites this paper
• Diabetic neuropathy in children.

  2014cites this paper
• Advanced glycation endproducts in food and their effects on health.

  2013cites this paper
• Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseases.

  2013cites this paper
• Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification

  2013cites this paper
• Protective mechanisms against oxidative stress and angiopathy in young patients with diabetes type 1 (DM1)

  2013cites this paper
• Advanced Glycation End Products Acutely Impair Ca2+ Signaling in Bovine Aortic Endothelial Cells

  2013cites this paper
• Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

  2012cites this paper
• The Role of Advanced Glycation Endproducts and Glyoxalase I in Diabetic Peripheral Sensory Neuropathy

  2012cites this paper
• Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging

  2010cites this paper
• Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.

  2010cites this paper
• Diabetes and the peripheral nerve.

  2009cites this paper
• Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.

  2009cites this paper
• Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.

  2009cites this paper
• Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus

  2009cites this paper
• Development and post-pilot modification of a questionnaire for assessing dietary AGE intake in Australian children with and without type 1 diabetes mellitus

  2008influential citation
• Role of advanced glycation end products in diabetic neuropathy.

  2008cites this paper
• Hyperglycemia-Initiated Mechanisms in Diabetic Neuropathy

  2007cites this paper
• RAGE Signaling in Cell Adhesion and Inflammation

  2007cites this paper
• Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes

  2007cites this paper
• Simultaneous determination of the advanced glycation end product Nɛ-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope-dilution–hydrophilic-interaction liquid chromatography coupled to tandem mass spectrometry

  2007cites this paper
• Current literature in diabetes

  2005cites this paper